eli lilly tirzepatide fda approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - What is OFF - LABEL

What the evidence shows: Semaglutide 3-month weight loss results Clinical trials show that most individuals using semaglutide for weight management lose 6-7% of their body weight within the first three months

These patients, like me, also had minimal side effects

However, these studies predominantly evaluated liraglutide and exenatide, not tirzepatide specifically

The origin and growth of renal calculi

This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2)

Inactive ingredients like sodium chloride, sodium phosphate dibasic heptahydrate, hydrochloric acid, and water for injection help maintain the solutions pH, stability, and comfort during injection